LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
LOGC
Delisted
LOGC was delisted on the 15th of November, 2022.
44 hedge funds and large institutions have $86M invested in LogicBio Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 3 closing their positions.
Holders
44
Holders Change
+4
Holders Change %
+10%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
7
Increased
18
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SC
1
Samlyn Capital
New York
|
$5.33M |
2 |
2
Morgan Stanley
New York
|
$311K |
3 |
3
BlackRock
New York
|
$3.64M |
4 |
FT
4
Fiduciary Trust
Boston,
Massachusetts
|
$223K |
5 |
OAM
5
Oxford Asset Management
Oxford,
United Kingdom
|
$136K |